Anti-Obinutuzumab/afutuzumab-CD20 antibody (STJA0032530)
SPECIFICATIONS
ClonalityMonoclonal
HostHumanized
ConjugationUnconjugated
IsotypeIgG1
General Information
| Short Description | Humanized monoclonal anti-Obinutuzumab/afutuzumab-CD20 for use in FUNC in Human samples. Datasheet included with dilution recommendations, and related reagents. |
| Applications | FUNC |
| Host | Humanized |
| Reactivity | Human |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Clonality | Monoclonal |
| Isotype | IgG1 |
| Conjugation | Unconjugated |
| Purification | Affinity Purified |
| Formulation | 0.01M PBS, pH 7.2 |
| Storage Instruction | This solution is stable for at least 4 weeks when stored at 2-8°C. For long term storage aseptically aliquot and store at –80°C. Avoid repeated freeze/thaw cycles. |
Target Information
Additional Info
| Background | Obinutuzumab biosimilar is a humanized anti-CD20 monoclonal antibody of the IgG1 subclass. It recognizes a specific epitope of the CD20 molecule found on B cells. The molecular mass of the antibody is approximately 150 kDa. it is produced by mammalian cell (CHO) suspension culture. It was engineered for reduced fucose content as compared to a typical IgG1 produced in CHO cells. |
Information sourced from Uniprot.org